Neurodegenerative diseases: Neurotoxins as sufficient etiologic agents?

NeuroMolecular Medicine

Volumn 10, Issue 1, 2008, Pages 1-9

  Shaw, Christopher A ^a   Höglinger, Günter U ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

ALS; Annonacin; Atypical parkinsonism; Cycad; Environmental toxins; Guadeloupe; Guam; MPTP; Neurological disease cluster; Parkinsonism dementia complex; Progressive subranuclear palsy; Sterol glucosides

Indexed keywords

NEUROTOXIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; DEGENERATIVE DISEASE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; PARKINSON DISEASE; PRIORITY JOURNAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DEMENTIA; GUADELOUPE; GUAM; HUMANS; MPTP POISONING; NEURODEGENERATIVE DISEASES; NEUROTOXINS; PARKINSON DISEASE, SECONDARY; PARKINSONIAN DISORDERS; TOXINS, BIOLOGICAL;

ANIMALIA; CYCADOPSIDA;

EID: 49249112467     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-007-8016-8     Document Type: Article

References (86)

1. P. M. Abou-Sleiman M. M. Muqit N. W. Wood 2006 Expanding insights of mitochondrial dysfunction in Parkinson's disease Natural Reviews Neuroscience 7 207 219
2. D. S. Albers R. H. Swerdlow G. Manfredi C. Gajewski L. Yang W. D. Parker Jr. M. F. Beal 2001 Further evidence for mitochondrial dysfunction in progressive supranuclear palsy Experimental Neurology 168 196 198
3. G. Angibaud C. Gaultier O. Rascol 2004 Atypical parkinsonism and Annonaceae consumption in New Caledonia Movement Disorders 19 603 604
4. P. A. Ballard J. W. Tetrud J. W. Langston 1985 Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): Seven cases Neurology 35 949 956
5. R. S. Bédlâck W. J. Strittmatter J. C. Morgenlander 2003 ApoIipoprotem E and neuromuscular disease: A critical review of the literature Archives of Neurology 57 1561 1565
6. E. Bezard C. E. Gross M. C. Fournier S. Dovero B. Bloch M. Jaber 1999 Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter Experimental Neurology 155 268 273
7. A. R. Borenstein J. A. Mortimer M. P. H. Schofield Y. Wu D. P. Salmon A. Gamst J. Olichney L. J. Thal L. Sibert J. Kaye U. L. Craig G. D. Schellenberg D. R. Galasko 2007 Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam Neurology 68 1764 1771
8. H. Braak E. Ghebremedhin U. Rub H. Bratzke K. Del Tredici 2004 Stages in the development of Parkinson's disease-related pathology Cell and Tissue Research 318 121 134
9. D. Caparros-Lefebvre A. Elbaz 1999 Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: A case-control study. Caribbean Parkinsonism Study Group Lancet 354 281 286
10. D. Caparros-Lefebvre N. Sergeant A. Lees A. Camuzat S. Daniel A. Lannuzel A. Brice E. Tolosa A. Delacourte C. Duyckaerts 2002 Guadeloupean parkinsonism: A cluster of progressive supranuclear palsy-like tauopathy Brain 125 801 811
11. D. Caparros-Lefebvre J. Steele Y. Kotake S. Ohta 2006 Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: Possible synergy of neurotoxins Movement Disorders 21 1769 1771
12. P. Champy G. U. Höglinger J. Feger C. Gleye R. Höcquemiller A. Laurens V. Guerineau O. Laprevote F. Medja A. Lombes P. P. Michel A. Lannuzel E. C. Hirsch M. Ruberg 2004 Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: Possible relevance for atypical parkinsonism in Guadeloupe Journal of Neurochemistry 88 63 69
13. P. Champy A. Melot V. Guerineau Eng C. Gleye D. Fall G. U. Höglinger M. Ruberg A. Lannuzel O. Laprevote A. Laurens R. Höcquemiller 2005 Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in Guadeloupe Movement Disorders 20 1629 1633
14. K. R. Chaudhuri M. T. Hu D. J. Brooks 2000 Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK Movement Disorders 15 18 23
15. R. Cruz-Aguado D. Winkler C. A. Shaw 2006 Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice Pharmacology, Biochemistry, and Behavior 84 294 299
16. A. C. D'Alessio M. Szyf 2006 Epigenetic tete-a-tete: The bilateral relationship between chromatin modifications and DNA methylation Biochemistry and Cell Biology 84 463 476
17. W. Dauer S. Przedborski 2003 Parkinson's disease: Mechanisms and models Neuron 39 889 909
18. G. P. Davey K. F. Tipton M. P. Murphy 1992 Uptake and accumulation of 1-methyl-4-phenylpyridinium by rat liver mitochondria measured using an ion-selective electrode The Biochemistry Journal 288 Pt 2 439 443
19. T. M. Dawson V. L. Dawson 2003 Molecular pathways of neurodegeneration in Parkinson's disease Science 302 819 822
20. M. Degli Esposti 1998 Inhibitors of NADH-ubiquinone reductase: An overview Biochimica Biophysica Acta 1364 222 235
21. R. S. Devon P. C. Orban K. Gerrow M. A. Barbieri C. Schwab L. P. Cao J. R. Helm N. Bissada R. Cruz-Aguado T. L. Davidson J. Witmer M. Metzler C. K. Lam W. Tetzlaff E. M. Simpson J. M. McCaffery A. E. El-Husseini B. R. Leavitt M. R. Hayden 2006 Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities Proceedings of the National Academy of Sciences of the United States of America 103 9595 9600
22. M. W. Duncan 1991 Role of the cycad neurotoxin BMAA in the amyotrophic lateral sclerosis-parkinsonism dementia complex of the western Pacific Advances in Neurology 56 301 310
23. M. W. Duncan J. C. Steele I. J. Kopin S. P. Markey 1990 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: An unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam Neurology 40 767 772
24. M. E. Emborg 2004 Evaluation of animal models of Parkinson's disease for neuroprotective strategies Journal of Neuroscience Methods 139 121 143
25. M. Escobar-Khondiker M. Höllerhage P. P. Michel M. P. Muriel P. Champy G. Respondek T. Yagi A. Lannuzel E. C. Hirsch W. H. Oertel R. Jacob R. Ruberg G. U. Höglinger 2007 Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons Journal of Neuroscience 27 7827 7837
26. F. Fornai O. M. Schluter P. Lenzi M. Gesi R. Ruffoli M. Ferrucci G. Lazzeri C. L. Busceti F. Pontarelli G. Battaglia A. Pellegrini F. Nicoletti S. Ruggieri A. Paparelli T. C. Sudhof 2005 Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and alpha-synuclein Proceedings of the National Academy of Sciences of the United States of America 102 3413 3418
27. L. S. Forno L. E. DeLanney I. Irwin J. W. Langston 1993 Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease Advances in Neurology 60 600 608
28. D. C. Gajdusek A. M. Salazar 1982 Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea Neurology 32 107 126
29. D. Galasko D. P. Salmon U. K. Craig L. J. Thal G. Schellenberg W. Wiederholt 2002 Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000 Neurology 58 90 97
30. R. E. Heikkila L. Manzino F. S. Cabbat R. C. Duvoisin 1984 Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6- tetrahydropyridine by monoamine oxidase inhibitors Nature 311 467 469
31. M. C. Hermosura H. Nayakanti M. V. Dorovkov F. R. Calderon A. G. Ryazanov D. S. Haymer R. M. Garruto 2005 A TRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders Proceedings of the National Academy of Sciences of the United States of America 102 11510 11515
32. A. Hirano L. T. Kurland R. S. Krooth S. Lessell 1961 Parkinsonism- dementia complex, an endemic disease on the island of Guam. I. Clinical features Brain 84 642 661
33. G. U. Höglinger J. Feger A. Prigent P. P. Michel K. Parain P. Champy M. Ruberg W. H. Oertel E. C. Hirsch 2003 Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats Journal of Neurochemistry 84 491 502
34. G. U. Höglinger A. Lannuzel M. E. Khondiker P. P. Michel C. Duyckaerts J. Feger P. Champy A. Prigent F. Medja A. Lombes W. H. Oertel M. Ruberg E. C. Hirsch 2005 The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy Journal of Neurochemistry 95 930 939
35. J. A. Javitch R. J. D'Amato S. M. Strittmatter S. H. Snyder 1985 Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity Proceedings of the National Academy of Sciences of the United States of America 82 2173 2177
36. J. P. Julien J. Kriz 2006 Transgenic mouse models of amyotrophic lateral sclerosis Biochimica Biophysica Acta 1762 1013 1024
37. P. M. Keeney J. Xie R. A. Capaldi J. P. Bennett Jr. 2006 Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled Journal of Neuroscience 26 5256 5264
38. I. Khabazian J. S. Bains D. E. Williams J. Cheung J. M. Wilson B. A. Pasqualotto S. L. Pelech R. J. Andersen Y. T. Wang L. Liu A. Nagai S. U. Kim U. K. Craig C. A. Shaw 2002 Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: Neurotoxicity and implications for ALS-parkinsonism dementia complex Journal of Neurochemistry 82 516 528
39. Khabazian, I., Pelech, S. L., Williams, D. L., Andersen, R. J., Craig, U. K., Krieger, C., & Shaw, C. A. (2000). Mechanisms of action of sitosterol glucoside in mammalian CNS. Society for Neuroscience Abstract.
40. L. T. Kurland 1972 An appraisal of the neurotoxicity of cycad and the etiology of amyotrophic lateral sclerosis on Guam Federation Proceedings 31 1540 1542
41. L. T. Kurland A. Hirano N. Malamud S. Lessell 1961 Parkinsonism-dementia complex, en endemic disease on the island of Guam. Clinical, pathological, genetic and epidemiological features Transactions of the American Neurological Association 86 115 120
42. L. T. Kurland D. W. Mulder 1954 Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations Neurology 4 355 378
43. J. W. Langston P. Ballard J. W. Tetrud I. Irwin 1983 Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 979 980
44. J. W. Langston L. S. Forno C. S. Rebert I. Irwin 1984 Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6- tetrahydropyrine (MPTP) in the squirrel monkey Brain Research 292 390 394
45. J. W. Langston I. Irwin E. B. Langston L. S. Forno 1984 Pargyline prevents MPTP-induced parkinsonism in primates Science 225 1480 1482
46. A. Lannuzel G. U. Höglinger S. Verhaeghe L. Gire S. Belson M. Escobar-Khondiker P. Poullain W. H. Oertel E. C. Hirsch B. Dubois M. Ruberg 2007 Atypical Parkinsonism in Guadeloupe: A common risk factor for two closely related phenotypes? Brain 130 816 827
47. A. Lannuzel P. P. Michel D. Caparros-Lefebvre J. Abaul R. Hocquemiller M. Ruberg 2002 Toxicity of Annonaceae for dopaminergic neurons: Potential role in atypical parkinsonism in Guadeloupe Movement Disorders 17 84 90
48. A. Lannuzel P. P. Michel G. U. Höglinger P. Champy A. Jousset F. Medja A. Lombes F. Darios C. Gleye A. Laurens R. Hocquemiller E. C. Hirsch M. Ruberg 2003 The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism Neuroscience 121 287 296
49. Ly, P. T. T., Liang, X. B., Wang, Q., Andreasson, K., & Shaw, C. A. (2006). The neurotoxic effects of -sitosterol glucosides in NSC 34 cells, a mouse motor neuron-derived cell line. Society for Neuroscience Abstract.
50. Ly, P. T., & Shaw, C. A. (2007). Steryl glycoside induced cytopathological changes in the motor neuron-derived NSC-34 cells. Society for Neuroscience Abstract.
51. P. T. Ly S. Singh C. A. Shaw 2007 Novel environmental toxins: Steryl glycosides as a potential etiological factor for age-related neurodegenerative diseases Journal of Neuroscience Research 85 231 237
52. V. M. Mann J. M. Cooper D. Krige S. E. Daniel A. H. Schapira C. D. Marsden 1992 Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease Brain 115 333 342
53. S. P. Markey J. N. Johannessen C. C. Chiueh R. S. Burns M. A. Herkenham 1984 Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism Nature 311 464 7
54. T. E. Marler V. Lee C. A. Shaw 2005 Spatial variation of steryl glucosides in Cycas micronesica plants-within and among plant sampling procedures Hort Science 40 1607 1611
55. T. E. Marler V. Lee C. A. Shaw 2005 Cycad toxins and neurological diseases in Guam: Defining theoretical and experimental standards for correlation human disease with environmental toxins Hort Science 33 1598 1606
56. R. Mayeux 2006 Genetic epidemiology of Alzheimer disease Alzheimer Disease and Associated Disorders 20 S58 62
57. W. J. Nicklas I. Vyas R. E. Heikkila 1985 Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine Life Sciences 36 2503 2508
58. T. L. Perry C. Bergeron A. J. Biro S. Hansen 1989 Beta-N-methylamino-L- alanine. Chronic oral administration is not neurotoxic to mice Journal of the Neurological Sciences 94 173 180
59. M. S. Petrik J. M. B. Wilson S. C. Grant S. J. Blackband R. C. Tabata X. Shan C. Krieger C. A. Shaw 2007 Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveal widespread neural deficits Journal of Neuromolecular Medicine 9 216 229
60. R. R. Ramsay T. P. Singer 1986 Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine, by mitochondria The Journal of Biological Chemistry 261 7585 7587
61. S. D. Rao S. A. Banack P. A. Cox J. H. Weiss 2006 BMAA selectively injures motor neurons via AMPA/kainate receptor activation Experimental Neurology 201 244 252
62. N. J. Riachi J. C. LaManna S. I. Harik 1989 Entry of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine into the rat brain The Journal of Pharmacology and Experimental Therapeutics 249 744 748
63. G. A. Ricaurte L. E. DeLanney I. Irwin J. W. Langston 1987 Older dopaminergic neurons do not recover from the effects of MPTP Neuropharmacology 26 97 99
64. G. A. Ricaurte J. W. Langston L. E. DeLanney I. Irwin J. D. Brooks 1985 Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum Neuroscience Letters 59 259 264
65. A. H. Schapira J. M. Cooper D. Dexter P. Jenner J. B. Clark C. D. Marsden 1989 Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1269
66. A. H. Schapira V. M. Mann J. M. Cooper D. Dexter S. E. Daniel P. Jenner J. B. Clark C. D. Marsden 1990 Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease Journal of Neurochemistry 55 2142 2145
67. T. P. Singer N. Castagnoli Jr. R. R. Ramsay A. J. Trevor 1987 Biochemical events in the development of parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine Journal of Neurochemistry 49 1 8
68. Slow, E. J., van Raamsdonk, J., Rogers, D., Coleman, S. H., Graham, R. K., Deng, Y., Oh, R., Bissada, N., Hossain, S. M., Yang, Y. Z., Li, X. J., Simposon, E. M., Gutekunst, C. A., Leavitt, B. R., & Hayden, M. R. (2003). Selective striatal neuronal loss in a YACI28 mouse model of Huntington disease. Human Molecular Genetics, 12, 1555-1567.
69. P. S. Spencer H. H. Schaumburg 1983 Lathyrism: A neurotoxic disease Neurobehavioral Toxicology and Teratology 5 625 629
70. Spencer, P. S., Nunn, P. B., Hugon, J., Ludolph, A. C., Ross, S. M., Roy, D. N., & Robertson, R. C. (1987). Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science, 237, 517-522.
71. J. C. Steele D. Caparros-Lefebvre A. J. Lees O. W. Sacks 2002 Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism- dementia complex and Guadeloupean parkinsonism Parkinsonism & Related Disorders 9 39 54
72. M. J. Strong 2003 The basic aspects of therapeutics in amyotrophic lateral sclerosis Pharmacology & Therapeutics 96 379 414
73. M. J. Strong G. M. Grace J. B. Orange H. A. Leeper R. S. Menon C. Aere 1999 A prospective study of cognitive impairment in ALS Neurology 53 1665 1670
74. Strong, M. J., Yang, W., Strong, W. L., Leystra-Lantz, C., Jaffe, H., & Pant, H. C. (2006). Tau protein hyperphosphorylation in sporadic ALS with cognitive impairment. Neurology, 66, 1770-1771.
75. R. H. Swerdlow L. I. Golbe J. K. Parks D. S. Cassarino D. R. Binder A. E. Grawey I. Litvan J. P. Bennett Jr. G. F. Wooten W. D. Parker 2000 Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy Journal of Neurochemistry 75 1681 1684
76. Tabata, R. C., Wilson, J. M. B., Ly, P., Zwiegers, P., Kwok, D., Van Kampen, J. M., Cashman, N., & Shaw, C. A. (2007). Chronic exposure to dietary sterol glucosides are neurotoxic to motor neurons and induce an ALS-PDC phenotype. Neurornolecular Medicine (in submission).
77. J. Q. Trojanowski T. Ishihara M. Higuchi Y. Yoshiyama M. Hong B. Zhang M. S. Forman V. Zhukareva V. M. Lee 2002 Amyotrophic lateral sclerosis/ parkinsonism dementia complex: Transgenic mice provide insights into mechanisms underlying a common tauopathy in an ethnic minority on Guam Experimental Neurology 176 1 11
78. Valentino, K. M., Dugger, N. V., Peterson, E., Wilson, J. M., Shaw, C. A., & Yarowsky, P. J. (2006). Environmentally-induced parkinsonism in cycad-fed rats. Society for Neuroscience Abstract.
79. J. H. Weiss J. Y. Koh D. W. Choi 1989 Neurotoxicity of beta-N-methylamino-L-alanine (BMAA) and beta-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons Brain Research 497 64 71
80. M. G. Whiting 1963 Toxicity of cycads Economic Botany 17 271 302
81. J. M. Wilson I. Khabazian M. C. Wong A. Seyedalikhani J. S. Bains B. A. Pasqualotto D. E. Williams R. J. Andersen R. J. Simpson R. Smith U. K. Craig L. T. Kurland C. A. Shaw 2002 Behavioral and neurological correlates of ALS-parkinsonism dementia complex in adult mice fed washed cycad flour Journal of Neuromolecular Medicine 1 207 221
82. J. M. Wilson M. S. Petrik S. C. Grant S. J. Blackband J. Lai C. A. Shaw 2004 Quantitative measurement of neurodegeneration in an ALS-PDC model using MR microscopy Neuroimage 23 336 343
83. J. M. Wilson M. S. Petrik M. H. Moghadasian C. A. Shaw 2005 Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC Canadian Journal of Physiology and Pharmacology 83 131 141
84. Wilson, J. M. B., Tabata, R. C., & Shaw, C. A. (2006). In vivo sterol glucoside neurotoxicity: Implications for ALS-PDC and ALS. Society for Neuroscience Abstract.
85. M. J. Winton S. Joyce V. Zhukareva D. Practico D. P. Perl D. Galasko U. Craig J. Q. Trojanowski V. M. Lee 2006 Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex Acta Neuropathologica (Berl). 111 401 412
86. Zimmerman, H. (1945). Progress report of work in the laboratory of pathology during May, 1945, Guam US Naval Medical Research Unit Number 2, June 1. Reported to US Navy and Public Health Service, Washington.